mitomycin has been researched along with Brain Hemorrhage in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Excerpt | Relevance | Reference |
---|---|---|
"A 50-year-old woman treated for breast cancer with mitomycin C developed severe hypertension, followed by deep coma 3 days later." | 3.71 | Hemolytic uremic syndrome with intracranial hemorrhage following mitomycin C administration. ( Katayama, Y; Kitamura, H; Komaba, Y; Nishiyama, Y, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nishiyama, Y | 1 |
Komaba, Y | 1 |
Kitamura, H | 1 |
Katayama, Y | 1 |
1 other study available for mitomycin and Brain Hemorrhage
Article | Year |
---|---|
Hemolytic uremic syndrome with intracranial hemorrhage following mitomycin C administration.
Topics: Alkylating Agents; Brain; Breast Neoplasms; Female; Hemolytic-Uremic Syndrome; Humans; Intracranial | 2001 |